[Elsevier] Comparative Efficacy and Safety of First-Line Treatment With Atezolizumab/Bevacizumab vs. Tyrosine-kinase Inhibitors in Patients With Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-analysis

doc14012002john Post time Half hour(s) ago | Show all posts |Read mode

This post will be closed automatically in 2026-09-19 16:59

Reward10points

journal：Journal of Clinical and Experimental Hepatology

Authors：Sakditad Saowapa; Natchaya Polpichai; Pojsakorn Danpanichkul; Romelia B. Bernal; Pharit Siladech; Lukman Tijani; Kenrick Ng; Yu J. Wong; Ashok Choudhury; Surasak Saokaew; Suthat Liangpunsakul; Apichat Kaewdech

Published date：2025-11-

DOI：10.1016/j.jceh.2025.102633

PDF link：https://www.sciencedirect.com/sc ... 973688325001331/pdf

Article link：https://doi.org/10.1016/j.jceh.2025.102633

Article Source：Elsevier BV。

Remark：

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report